NasdaqCM - Delayed Quote USD

Mangoceuticals, Inc. (MGRX)

2.0400
0.0000
(0.00%)
At close: June 6 at 4:00:01 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jacob D. Cohen Co-Founder, CEO & Chairman 350k -- 1979
Mr. Eugene M. Johnston Chief Financial Officer 56k -- 1964
Ms. Amanda Elizabeth Hammer Chief Operating Officer 150k -- 1986
Mr. Antonios Isaac President & Director -- -- 1955

Mangoceuticals, Inc.

15110 N. Dallas Parkway
Suite 600
Dallas, TX 75248
United States
214 242 9619 https://www.mangoceuticals.com
Sector: 
Healthcare
Full Time Employees: 
3

Description

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Corporate Governance

Mangoceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 30, 2025 at 12:00 AM UTC

S-1: Offering Registrations

May 23, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 6, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 25, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 17, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 8, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 2, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 1, 2025 at 12:00 AM UTC

S-8: Offering Registrations

Related Tickers